Pashman Stein Walder Hayden P.C. Team Successfully Wins Approval and Closes Sale for Taran Therapeutics, Inc. as Successful Bidder in Humanigen Inc.’s Filing for Chapter 11 Bankruptcy in Delaware
Pashman Stein Walder Hayden P.C. lawyers Henry J. Jaffe, Joseph C. Barsalona II, J. John Kim and Richard C. Solow, have represented Taran Therapeutics, Inc. (“Taran”) in its role as stalking horse purchaser and debtor-in-possession lender in Humanigen Inc.’s filing for Chapter 11 Bankruptcy in Delaware. This team was successful in securing a deal approval for client Taran at a court hearing on February 14, 2024. On Tuesday, February 20, the sale officially closed.
The Bankruptcy, Restructuring & Creditors’ Rights and Litigation practices at Pashman Stein were mentioned in a Law360 article titled “Pharma Co. Humanigen Gets OK For Ch. 11 Sale.” Biopharmaceutical company Humanigen Inc. filed for Chapter 11 bankruptcy in Delaware after failing to receive emergency authorization for a COVID-19 treatment.
To read the full Law360 article, click here.
This story also received coverage in CityBiz, which can be read here.
Our firm is proud of the results it has achieved for clients, some of which are noted here. Of course, each legal matter is unique on many levels, and past successes are not a guarantee of results in any other pending or future matters.
